Indian Rival Meril Accuses Edwards Lifesciences Of Anti-Competitive Behavior In EU Antitrust Complaint [Yahoo! Finance]
Edwards Lifesciences Co. (NYSE: EW) was upgraded by analysts at Deutsche Bank Aktiengesellschaft from a "hold" rating to a "buy" rating.
Global Cardiac Surgery Market Analysis 2024: Innovative Cardiac Procedures Drive Market Expansion with 5.5% CAGR through 2030 [Yahoo! Finance]
Edwards Lifesciences hit with Meril's EU antitrust complaint [Reuters]
Investors in Edwards Lifesciences (NYSE:EW) have seen respectable returns of 50% over the past five years [Yahoo! Finance]